The rapid onset and intensity of the COVID-19 pandemic has required some radical changes in most areas of our professional lives, including a chance to update traditional approaches to learning. Virtual learning is the use of remote video conferencing software,...
IBSA Derma launch their first virtual conference IBSA Derma developed and hosted their first virtual conference on 12-15 June 2020 in IBSA World; an innovative online space reserved for doctors. With the objective of combining a digital experience with a...
The leading experts in UK aesthetic medicine are meeting for the 2020 British College of Aesthetic Medicine’s (BCAM) first 'Virtual Conference' on 14-19 September.The College has a full week packed with bite-sized virtual meetings in the evenings of 14-18 September...
IBSA Derma host their 2nd Virtual Congress On 28 November 2020, IBSA Derma welcomed cosmetic doctors and aesthetic professionals from all over the word to the 2nd edition of their Virtual Congress. With a focus on PROFHILO®, a flagship of...
The Aesthetic Multispecialty Society (AMS), in partnership with AMWC, are launching their first-ever digital event on 3-4 June. The AMS Virtual conference will be presented in a novel TALK-SHOW format, led by some of the most noteworthy practitioners of our...
Virtual product launch: Meder Beauty’s Circa-Night Cream In June Meder Beauty held a virtual event to launch their new product, Meder Beauty’s Biohacking Circa-Night Cream.The launch began with an overview by aesthetic dermatologist Dr Tina Meder, who launched Meder Beauty...
During the Corona virus shutdown, ThermaVein urgently needed to find a new way to support customers and continue to market the ThermaVein system. The problem was, to offer our usual high standards, we would need...
This CPD accredited virtual event taking place over the course of 2days, aims to build on the successes of the last eleven years and will explore the treatment options available for recurrent cancer in the head and neck setting.
This CPD accredited virtual event taking place over the course of 2days, aims to build on the successes of the last eleven years and will explore the treatment options available for recurrent cancer in the head and neck setting.